Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 5/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | CTSS | P25774 | 2/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.40 |
| ▸ | SIRT3 | Q9NTG7 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5747993 | 0.91 | PTGER4 (0.44) | PTGER4HDAC4HDAC1HDAC6CTSS | |
| SCHEMBL5652884 | 0.90 | PTGER4 (0.47) | PTGER4HDAC4HDAC1HDAC6CTSS | |
| SCHEMBL5653452 | 0.90 | PTGER4 (0.46) | PTGER4HDAC4HDAC1HDAC6CTSS | |
| SCHEMBL5654596 | 0.85 | PTGER4 (0.51) | PTGER4CTSSCTSLSIRT5SIRT1 | |
| SCHEMBL5655260 | 0.84 | PTGER4 (0.45) | PTGER4HDAC1HDAC6CTSSCTSL | |
| SCHEMBL5655265 | 0.84 | PTGER4 (0.45) | PTGER4HDAC1HDAC6CTSSCTSL | |
| SCHEMBL12193390 | 0.84 | PTGER4 (0.54) | PTGER4HDAC1CTSSCTSLSIRT1 | |
| SCHEMBL5653800 | 0.84 | PTGER4 (0.46) | PTGER4HDAC1CTSSCTSLSIRT5 | |
| SCHEMBL5823969 | 0.82 | PTGER4 (0.47) | PTGER4CTSSCTSLSIRT1SIRT2 | |
| SCHEMBL5653738 | 0.82 | CTSS (0.47) | PTGER4CTSSCTSLSIRT5SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1697337-A2 | ORNITHINE DERIVATIVES AS PROSTAGLANDIN-E2-AGONISTS OR ANTAGONISTS | Astellas Pharma Inc. (JP) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005061475-A2 | ORNITHINE DERIVATIVES AS PROSTAGLANDIN E2 AGONISTS OR ANTAGONISTS | ASTELLAS PHARMA INC. (JP) | 2005-07-07 | — | — | WO | disclosed |